Logo do repositório
 
A carregar...
Logótipo do projeto
Projeto de investigação

Algarve Centre for Marine Sciences

Autores

Publicações

A guide to the use of bioassays in exploration of natural resources
Publication . Sabotič, Jerica; Bayram, Engin; Ezra, David; Gaudêncio, Susana P.; Haznedaroğlu, Berat Z.; Janež, Nika; Ktari, Leila; Luganini, Anna; Mandalakis, Manolis; Safarik, Ivo; Simes, Dina; Strode, Evita; Toruńska-Sitarz, Anna; Varamogianni-Mamatsi, Despoina; Varese, Giovanna Cristina; Vasquez, Marlen I.; UCIBIO - Applied Molecular Biosciences Unit; DQ - Departamento de Química; Elsevier Science B.V., Amsterdam.
Bioassays are the main tool to decipher bioactivities from natural resources thus their selection and quality are critical for optimal bioprospecting. They are used both in the early stages of compounds isolation/purification/identification, and in later stages to evaluate their safety and efficacy. In this review, we provide a comprehensive overview of the most common bioassays used in the discovery and development of new bioactive compounds with a focus on marine bioresources. We present a comprehensive list of practical considerations for selecting appropriate bioassays and discuss in detail the bioassays typically used to explore antimicrobial, antibiofilm, cytotoxic, antiviral, antioxidant, and anti-ageing potential. The concept of quality control and bioassay validation are introduced, followed by safety considerations, which are critical to advancing bioactive compounds to a higher stage of development. We conclude by providing an application-oriented view focused on the development of pharmaceuticals, food supplements, and cosmetics, the industrial pipelines where currently known marine natural products hold most potential. We highlight the importance of gaining reliable bioassay results, as these serve as a starting point for application-based development and further testing, as well as for consideration by regulatory authorities.
A demographic model to forecast Dinophysis acuminata harmful algal blooms
Publication . Vieira, Vasco Manuel Nobre de Carvalho da Silva; Rosa, Teresa Leal; Sobrinho-Gonçalves, Luís; Mateus, Marcos Duarte; Mota, Bernardo; MARE - Centro de Ciências do Mar e do Ambiente; Frontiers Media
Harmful algal blooms (HABs) in marine environments have significant adverse effects on public health, aquaculture and recreational activities. Surges of certain phytoplanktonic toxin-producing microalgae (mostly dinoflagellates or diatoms species) can induce Amnesic, Diarrhetic or Paralytic Shellfish Poisoning (ASP, DSP and PSP). Among HAB species, the genus Dinophysis leads to DSP in human consumers; this being the most recurrent problem in the Iberian Peninsula with the biggest economic impact on clam production and harvesting. While complete elimination of HABs is not feasible, timely implementation of appropriate measures can prevent their negative consequences. This is critical for aquaculture. Research on D. acuminata (dominant Dinophysis species in the North Atlantic) has been focused on ecophysiology and population dynamics, although with few modelling attempts. Weekly monitoring along the Portuguese coast since 2006 has revealed that D. acuminata thrives under spring/summer photosynthetically active radiation (PAR) coupled with water temperatures below 20°C, which typically coincide with the local upwelling regime. In order to advance this knowledge numerically, we developed a demographic model linking D. acuminata growth rate to PAR and sea surface temperature (SST). The 13-year (1-Jan-2006 to 31-Dec-2018) time-series of observations was closely fit by model forecasts. However, the model demonstrated limitations in issuing timely warnings of harmful proliferation of D. acuminata, failing to do so in 50% of cases, and issuing incorrect warnings in 5% of the cases. Furthermore, improving the odds of emitting timely warnings always worsened the odds of emitting false warnings, and vice-versa. To simultaneously improve both aspects, the modelling results clearly indicated the need of implementing both census/projection intervals smaller than 7 days and a laboratory detection limit below 20 cell/L. The time resolution of the census and of the model proved to be the most limiting factor that must be addressed in order to improve numerical forecasting of HABs.
Random Mutagenesis as a Promising Tool for Microalgal Strain Improvement towards Industrial Production
Publication . Trovão, Mafalda; Schüler, Lisa M.; Machado, Adriana; Bombo, Gabriel; Navalho, Sofia; Barros, Ana; Pereira, Hugo; Silva, Joana; Freitas, Filomena; Varela, João; DQ - Departamento de Química; UCIBIO - Applied Molecular Biosciences Unit; MDPI - Multidisciplinary Digital Publishing Institute
Microalgae have become a promising novel and sustainable feedstock for meeting the rising demand for food and feed. However, microalgae‐based products are currently hindered by high production costs. One major reason for this is that commonly cultivated wildtype strains do not possess the robustness and productivity required for successful industrial production. Several strain improvement technologies have been developed towards creating more stress tolerant and productive strains. While classical methods of forward genetics have been extensively used to determine gene function of randomly generated mutants, reverse genetics has been explored to generate specific mutations and target phenotypes. Site‐directed mutagenesis can be accomplished by employing different gene editing tools, which enable the generation of tailor‐made genotypes. Nevertheless, strategies promoting the selection of randomly generated mutants avoid the introduction of foreign genetic material. In this paper, we review different microalgal strain improvement approaches and their applications, with a primary focus on random mutagenesis. Current challenges hampering strain improvement, selection, and commercialization will be discussed. The combination of these approaches with high‐throughput technologies, such as fluorescence‐activated cell sorting, as tools to select the most promising mutants, will also be discussed.
Revealing the role of crab as bait in octopus fishery
Publication . Leitão, Francisco; Monteiro, João N.; Cabral, Pedro; Teodósio, Maria A.; Roa-Ureta, Ruben H.; Information Management Research Center (MagIC) - NOVA Information Management School; NOVA Information Management School (NOVA IMS); Elsevier
In southern Portugal, artisanal octopus fisheries play an important socioeconomic role. Live crab bait in traps was used up to 2010 and banned in 2012. Such regulation, based on co-management advice, was not established under a scientific fundament. As a result, a long-standing controversy ensued with some fishing associations claiming that live crab bait increased fishing effort and exploitation rates and therefore risked the octopus stock status, while other fishers denied all these alleged impacts. The issue has not been resolved so far due to lack of scientific studies. In this study, we resolve the controversy conducting experimental fishing to determine by-catch and octopus catch rates using live crab bait versus other types of baits based on fish and assess the stock status of octopus over-time with constant parameters (hypothesis of no effect of the use of live crab bait) versus time-varying parameters (hypothesis of raised exploitation rates and riskier stock status). Bycatch was very low regardless of bait type. Our experimental fishing trials showed that fish-based baits increase bycatch and octopus catch rates. Stock assessment models showed that exploitation rates and stock status do not worsen in years of use of crab bait. We conclude that the use of crab bait in octopus fishery does not lead to increased exploitation rate or risks for stock sustainability status. Other considerations involving fishing costs and fishing operations further highlight the advantages of lifting the ban on the use of live crab bait in the Algarve octopus fishery.
Nanoencapsulation of Gla-Rich Protein (GRP) as a Novel Approach to Target Inflammation
Publication . Viegas, Carla S. B.; Araújo, Nuna; Carreira, Joana; Pontes, Jorge F.; Macedo, Anjos L.; Vinhas, Maurícia; Moreira, Ana S.; Faria, Tiago Q.; Grenha, Ana; de Matos, António A.; Schurgers, Leon; Vermeer, Cees; Simes, Dina Costa; UCIBIO - Applied Molecular Biosciences Unit; DQ - Departamento de Química; Instituto de Tecnologia Química e Biológica António Xavier (ITQB); MDPI - Multidisciplinary Digital Publishing Institute
Chronic inflammation is a major driver of chronic inflammatory diseases (CIDs), with a tremendous impact worldwide. Besides its function as a pathological calcification inhibitor, vitamin K-dependent protein Gla-rich protein (GRP) was shown to act as an anti-inflammatory agent independently of its gamma-carboxylation status. Although GRP’s therapeutic potential has been highlighted, its low solubility at physiological pH still constitutes a major challenge for its biomedical application. In this work, we produced fluorescein-labeled chitosan-tripolyphosphate nanoparticles containing non-carboxylated GRP (ucGRP) (FCNG) via ionotropic gelation, increasing its bioavail-ability, stability, and anti-inflammatory potential. The results indicate the nanosized nature of FCNG with PDI and a zeta potential suitable for biomedical applications. FCNG’s anti-inflammatory activity was studied in macrophage-differentiated THP1 cells, and in primary vascular smooth muscle cells and chondrocytes, inflamed with LPS, TNFα and IL-1β, respectively. In all these in vitro human cell systems, FCNG treatments resulted in increased intra and extracellular GRP levels, and decreased pro-inflammatory responses of target cells, by decreasing pro-inflammatory cytokines and inflammation mediators. These results suggest the retained anti-inflammatory bioactivity of ucGRP in FCNG, strengthening the potential use of ucGRP as an anti-inflammatory agent with a wide spectrum of application, and opening up perspectives for its therapeutic application in CIDs.

Unidades organizacionais

Descrição

Palavras-chave

Contribuidores

Financiadores

Entidade financiadora

Fundação para a Ciência e a Tecnologia

Programa de financiamento

6817 - DCRRNI ID

Número da atribuição

UIDP/04326/2020

ID